About Asensus
Asensus is a company based in Durham (United States) founded in 2006 was acquired by Karl Storz in August 2024. Asensus has raised $91.18 million across 6 funding rounds from investors including SafeStitch, Karl Storz and Sofar. Asensus has completed 2 acquisitions, including ALF-X Robot and Modern Systems Talk. Asensus offers products and services including Senhance Surgical System, Intelligent Surgical Unit, and Senhance Connect. Asensus operates in a competitive market with competitors including Brainlab, PROCEPT BioRobotics, Auris Health, Intuitive and Medical Microinstruments, among others.
- Headquarter Durham, United States
- Stage Public
-
Sectors
HealthcareIndustrial Goods & Manufacturing
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Asensus Surgical, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$91.18 M (USD)
in 6 rounds
-
Latest Funding Round
$5.2 M (USD), Post-IPO
Jan 05, 2017
-
Investors
SafeStitch
& 8 more
-
Employee Count
Not available
-
Investments & Acquisitions
ALF-X Robot
& 1 more
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Asensus
Asensus offers a comprehensive portfolio of products and services, including Senhance Surgical System, Intelligent Surgical Unit, and Senhance Connect.
Provides control and real-time insights for safer surgical procedures
Offers digital insights to enhance surgical decision-making and efficiency
Facilitates connectivity for improved surgical collaboration and support
People of Asensus
Unlock access to complete
Unlock access to complete
Funding Insights of Asensus
Asensus has successfully raised a total of $91.18M across 6 strategic funding rounds. The most recent funding activity was a Post-IPO round of $5.2 million completed in January 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Asensus
Asensus has secured backing from 9 investors, including institutional and venture fund investors. Prominent investors backing the company include SafeStitch, Karl Storz and Sofar.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
PE firm investing in the US
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Early-stage life sciences and tech focused VC firm funding companies in the US
|
Locked | Locked | Locked |
Investor details for Asensus
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Asensus
Asensus has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include ALF-X Robot and Modern Systems Talk.
Investment portfolio details for Asensus
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
A miniature robotic system for image-guided laparoscope positioning is provided.
|
Locked | Locked | 2005 | Locked | |
|
Robotic surgery system with tactile sensitivity
|
Locked | Locked | 1968 | Locked |
Complete acquisition details for Asensus
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Asensus
Detailed financials for Asensus
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Asensus Comparisons
Peer comparison for Asensus
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Asensus
Asensus operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Brainlab, PROCEPT BioRobotics, Auris Health, Intuitive and Medical Microinstruments, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Software and integrated solutions for surgical and radiotherapy applications
|
|
| Locked | Locked | Locked |
Robotic waterjet system for prostate tissue removal is developed.
|
|
| Locked | Locked | Locked |
Robotic microsurgical systems for endoscopy are developed.
|
|
| Locked | Locked | Locked |
Robotic-assisted surgical systems are developed for minimally invasive procedures.
|
|
| Locked | Locked | Locked |
A robotic platform is used for microsurgery with scaled instruments.
|
Detailed competitors of Asensus
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Asensus
Complete news archive for Asensus
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Asensus
Asensus was founded in 2006 and raised its 1st funding round 1 year after it was founded.
Asensus is headquartered in Durham, United States. It is registered at Durham, North Carolina, United States.
Anthony Fernando is the current CEO of Asensus.
Asensus is a funded company, having raised a total of $91.18M across 6 funding rounds to date.
Founded in 2006 and headquartered in Durham, United States, Asensus operates in the medical technology sector. Robotic systems for laparoscopic procedures are developed, including a digital platform that enables surgeon-patient interaction during operations. These systems are applied in general surgery and gynecological laparoscopic interventions, supporting minimally invasive techniques across clinical settings.
Asensus's top competitors include Brainlab, PROCEPT BioRobotics and Auris Health.
Asensus offers Senhance Surgical System, Intelligent Surgical Unit, and Senhance Connect.
Asensus has made 2 acquisitions, including ALF-X Robot, and Modern Systems Talk.
Asensus has 9 investors. Key investors include SafeStitch, Karl Storz, Sofar, Aisling Capital, and Synergy Life Science Partner.